Loading...
Comparative metabolomics reveals key pathways associated with the synergistic activity of polymyxin B and rifampicin combination against multidrug-resistant Acinetobacter baumannii
Multidrug-resistant (MDR) Acinetobacter baumannii presents a critical challenge to human health worldwide and polymyxins are increasingly used as a last-line therapy. Due to the rapid emergence of resistance during polymyxin monotherapy, synergistic combinations (e.g. with rifampicin) are recommende...
Na minha lista:
| Udgivet i: | Biochem Pharmacol |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7906441/ https://ncbi.nlm.nih.gov/pubmed/33387481 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bcp.2020.114400 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|